Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Mol Genet Metab. 2010 May 23;100(4):333–338. doi: 10.1016/j.ymgme.2010.04.014

Figure 2.

Figure 2

Western blotting of an SDS-PAGE gel of expressed SBCAD patient point mutations. The arrow shows the migration position of purified recombinant SBCAD. Wild type SBCAD expressed in E. coli yields a high level of SBCAD antigen in crude cell extracts. The Glu387Lys and Thr148Ilu are minimally or not detectable.

HHS Vulnerability Disclosure